Vishal N. Jajodia

Mr. Vishal Jajodia is a new-age social entrepreneur specializing in areas of neglected and orphan diseases. He has 25 years of experience in the industry and has held important positions in export promotion councils under the ministry of commerce and has participated in policy-forming committees. He had a drug discovery informatics company during the early 2000s and has done several projects related to proteomics, genomics, and drug target identification using artificial intelligence and machine learning tools.

Currently, his flagship company M/s Swati Spentose Pvt. Ltd. with a manufacturing base out of Vapi has invested over USD 20 million across manufacturing and research platforms, including launching and promoting new health solutions in debilitating diseases in urology and nephrology, with research sponsored at prestigious Mt Sinai School of Medicine, New York – USA.

They have for the first time in the world, launched a generic drug where the treatment cost was USD 25000, and only been available in the US for over 20 years now have made the same available in India and 4 more countries at approximately 1200 USD (5% of the originator). They also currently hold patents on diseases related to kidneys where presently there are no medicines available to suffering patients. They are also working on rare diseases like Mucopolysaccharidosis which is bone inflammation leading to dwarfism.

He is committed to harnessing new business models of social entrepreneurship to develop community shared value formats as originally conceptualized by global thought leaders like Michael Porter.

He also has several environmental initiatives, again harnessing community shared value business models, across corporate farming, water conservation, and environmentally sustainable industrialization in symbiotic relation with villagers leading to rubinazation (rural urbanization).